Efficacy and Safety of a Combination of Thrombopoietin Receptor Agonist with an Immunosuppressant Therapy for the Management of Multirefractory Adult ITP: Results from a Retrospective, Multicenter, Observational Study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Blood Année : 2020

Efficacy and Safety of a Combination of Thrombopoietin Receptor Agonist with an Immunosuppressant Therapy for the Management of Multirefractory Adult ITP: Results from a Retrospective, Multicenter, Observational Study

(1) , (2) , (3) , (4) , (5, 6) , (7) , (8) , (9) , (10, 11) , (12) , (12) , (13)
1
2
3
4
5
6
7
8
9
10
11
12
13

Dates et versions

hal-03604937 , version 1 (10-03-2022)

Identifiants

Citer

Etienne Crickx, Guillaume Moulis, Marc Ruivard, Bouchra Asli, Jean Pierre Marolleau, et al.. Efficacy and Safety of a Combination of Thrombopoietin Receptor Agonist with an Immunosuppressant Therapy for the Management of Multirefractory Adult ITP: Results from a Retrospective, Multicenter, Observational Study. Blood, 2020, 136 (1), ⟨10.1182/blood-2020-143031⟩. ⟨hal-03604937⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More